AI isn’t just a tool—it’s a team member. That’s the bold vision that my colleague, Scott Snyder, Chief Digital Officer at EVERSANA, shared in a recent interview with pharmaphorum.
Scott’s interview does a great job highlighting how AI agents present countless opportunities to transform pharma commercialization—from accelerating launch timelines to reshaping workforce roles.
The article dives into the urgency of AI adoption, the pitfalls of scattered experimentation, and the need for end-to-end transformation. From campaign strategy to patient outcomes, the article explores pharma’s future with AI-enabled experiences that empower both employees and patients.
“Think of one human working with four AI workers. We wanted to set a bold target; otherwise, people fall back to incremental thinking.” – Scott Snyder, Chief Digital Officer
Read the full article to discover how AI agents are reshaping the future of pharma commercialization.
Author
Faruk is EVERSANA’s Chief Innovation Officer and the Chief Executive Officer of EVERSANA INTOUCH, the best-in-class full-service marketing and creative agency of more than 1,500 employees globally that joined EVERSANA in December 2021. Faruk…